Glaucoma After Congenital Cataract Surgery
Glaucoma After Congenital Cataract Surgery
Glaucoma After Congenital Cataract Surgery
Mahmoodreza Panahi Bazaz, MD1 Farideh Sharifipour, MD2 Mitra Zamani, MD2
Ali Sadeghi, MD3 Hossein Roostai, MD3 Seyed Mahmood Latifi, MSc4
Abstract
Purpose: To determine the incidence and risk factors associated with glaucoma following
congenital cataract surgery (CCS) in children under age of 15
Methods: This prospective cohort (since 2006) consisted of children less than 15 years of age who
underwent cataract surgery with or without intraocular lens (IOL) implantation. The role of the
following factors on the development of glaucoma after CCS including age at surgery, gender,
laterality of the cataract, IOL implantation, congenital ocular anomalies, intra- and postoperative
complications, length of follow-up, central corneal thickness (CCT) as well as the effect of the age
of onset, time to development of glaucoma, and response to treatment were evaluated.
Results: Overall, 161 eyes of 96 patients were included in this study of which 28 eyes developed
glaucoma. Incidence of glaucoma was 17.4%. MeanSD age at surgery was 9.36.9 (range, 1-24)
months in glaucomatous and 40.441.1 (range, 1 m-13.6 year) months in non-glaucomatous group
(p<0.001). All glaucoma patients had the operation under two years of age. In group 1, 9 (60%)
and in group 2, 24 (30%) patients were female (p=0.001). In group 1, 17 eyes (60.7%) and in the
group 2, 41 eyes (30.8%) were aphakic (p=0.001). Mean time to diagnosis of glaucoma was 111.2
days (range 30-1200 days). Mean follow-up time was 3.1 years (range, 1-6 years). In 22 (78.6%)
eyes glaucoma was diagnosed within six months after surgery. Glaucoma was controlled with
medications in 23 eyes (82%) and with surgery in five eyes.
Conclusion: In this study the incidence of glaucoma after CCS was 17.4% over a follow-up period
of six years. Younger age at the time of lensectomy increases the risk of secondary glaucoma. IOL
implantation may protect against glaucoma. Female gender was affected more than male.
Keywords: Secondary Glaucoma, Congenital Cataract, Cataract Surgery
Iranian Journal of Ophthalmology 2014;26(1):11-16 2014 by the Iranian Society of Ophthalmology
1. Assistant Professor of Ophthalmology, Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of
Medical Sciences, Ahvaz, Iran
2. Associate Professor of Ophthalmology, Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of
Medical Sciences, Ahvaz, Iran
3. Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4. Department of Biostatistics, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Received: December 9, 2013
Accepted: May 7, 2014
Correspondence to: Farideh Sharifipour, MD
Associate Professor of Ophthalmology, Department of Ophthalmology, Imam Khomeini Hospital, Ahvaz Jundishapur University of
Medical Sciences, Ahvaz, Iran, Email: sharifipourf@yahoo.com
Financial support: None
2014 by the Iranian Society of Ophthalmology
Published by Otagh-e-Chap Inc.
11
Introduction
Glaucoma is one of the most important
complications of congenital cataract surgery
(CCS). It may present as angle closure
glaucoma shortly after the surgery or later as
an open angle type.1 Although different
pathogenetic
mechanisms
have
been
proposed, the exact mechanism remains
unknown.1 The reported incidence for this
varies from 6% to 58.7% based on the length
of follow-up.2-6 Glaucoma in these eyes has a
slow and progressive course. It may occur
years after surgery and the diagnosis is often
difficult.1 Therefore, children who undergo
lensectomy remain at risk of developing
glaucoma throughout their lives.3
Studies have shown that ocular anomalies
like
micropthalmia,7
microcornea
and
persistent fetal vasculatue (PFV) may be
associated with glaucoma after surgery.2,4,8
Currently, the age of the patient at the time
of surgery is a known risk factor for
developing glaucoma after the cataract
surgery.4,6,7,9-13 Primary intraocular lens (IOL)
implantation is currently used in children older
than two years of age 14 and IOL implantation
in newborns and infants has gradually gained
popularity among the surgeons.15,16 There is
growing evidence that the incidence of
glaucoma
is
significantly
lower
in
pseudophakic eyes compared to aphakic
eyes17 leading to the hypothesis of the
possible protective role of IOL.18
Treatment of aphakic glaucoma is difficult
and controversial. In contrast to primary
congenital glaucoma, medication is the
mainstay of treatment with limited role and
surgical procedures have poor prognosis.11,19
Since secondary glaucoma following the
cataract surgery is the leading cause of visual
loss years after the surgery, better
understanding the pathogenesis and potential
risk factors are of paramount importance.
In this study, we evaluated the incidence
and risk factors associated with glaucoma
after surgery for congenital or developmental
cataract.
Methods
This prospective cohort has been underway
since 2006. The study was approved by the
ethics committee of Ahvaz Jundishapur
University of Medical Sciences, Ahvaz, Iran
12
Results
Overall, 161 eyes of 96 patients that
underwent lensectomy with anterior vitrectomy
with or without IOL insertion were followed for
a mean period of 3.1 years (range, 1-6 years).
Congenital cataract was the cause of surgery
in all cases. Glaucomatous group consisted of
28 eyes and non-glaucomatous group
included 133 eyes. The incidence of
secondary glaucoma was 17.4% over this
period. Demographic data and the patients
characteristics are summarized in table 1.
At the time of surgery, there was no
significant difference between the two groups
in terms of study parameters except for age.
Glaucomatous group was younger at the time
of the cataract surgery compared to
nonglaucomatous group (p<0.001). In group
1, 15 eyes (53.6%) had surgery between three
to five months of age. No patient operated
between seven to 10 months of age
developed glaucoma.
Mean time to glaucoma diagnosis was 111.2
days (range, 30-1,200 days) after surgery.
13
Gender
F(%)
9 (60)
24 (30)
0.19
glaucomatous
Non-glaucomatous
p
28/15 (17.4%(
133/81
Age at surgery
(months)
9.3 (6.9)
40.4 (41.1)
<0.001
CCT
(m)
62694
62773
0.946
17 (60.7)
41 (30.9)
0.001
Table 2. Age distribution of the patients with (group 1) and without (group 2)
glaucoma at the time of cataract surgery and glaucoma diagnosis
Age distribution
at the time of cataract surgery
Group
1
2
<1 year
24 eyes (85.7%)
47 eyes (35.3%)
>1 year
4 eyes (14.3%)
86 eyes (64.7%)
18 eyes (64.2%)
10 eyes (35.8%)
Glaucomatous Group
Non-glaucomatous Group
Odds Ratio
9 (60%)
9.36.9
17 (60.8%)
3 (10%)
13 patients (92.9%)
24 (30)
40.441.1
41 (30.9%)
6 (4%)
52 patients (64.2%)
0.19
<0.001
0.001
0.579
0.09
1.2
4.22
2.45
1.53
1.53
Discussion
Glaucoma
after
the
congenital
or
developmental cataract surgery is a major
cause of visual loss in these patients. In our
study, the incidence of this complication was
Table 4. Review of studies reporting incidence of glaucoma and potential risk factors after pediatric cataract surgery
Study
Year
Incidence of
glaucoma (%)
Mean follow-up
(years)
Chrousos et al2
1984
6.1
5.5
Keech et al23
1989
11
3.6
Simon et al3
1991
24
6.8
1994
15.8
7.4
<1 y
2000
12
9.6
<10 d
2002
26
9.7
2004
21
<9 m
2006
58.7
124 m (10.3)
1y
2007
15.4
6.3
<9 m
Haargaard
2008
31.9
10
<9 m
Current study
2013
17.4
3.1
<1 y
Magnusson et al
Miyahara et al
Rabiah20
Chen et al6
Swamy et al
11
13
14
Age
<8 w
f/u time
congenital rubella syndrome, poor
pupillary dilation, microcornea
Microphthalmos
Microcornea, microphthalmos
secondary membrane surgery,
primary posterior
capsulotomy/anterior vitrectomy,
microcornea
cataract type, Postoperative
cycloplegic use, microcornea
f/u time, microcornea
Aphakia
Conclusion
This study revealed younger age at the time of
surgery, aphakia as the major risk factors for
development of glaucoma. However, surgery
should not be delayed due to the risk of
profound amblyopia. Most glaucoma cases
are diagnosed within one year after cataract
surgery. In most patients glaucoma was
managed with medications.
References
1.
2.
3.
4.
5.
6.
7.
8.
16
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.